Join to View Full Profile
1500 E Medical Center DrAnn Arbor, MI 48109
Phone+1 734-936-4000
Dr. Agrusa is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jennifer Agrusa is a pediatric hematologist/oncologist in Ann Arbor and is affiliated with the University of Michigan. She received her medical degree from NYU School of Medicine and completed her fellowship training at Texas Children's Hospital in 2017, where she remained for 5 additional years. She is experienced in pediatric leukemia and lymphoma, CAR T cell therapy, and survivorship.
Education & Training
Baylor College of MedicineMS, Clinical Investigation , 2016 - 2019
Baylor College of MedicineFellowship, Pediatric Hematology/Oncology, 2014 - 2017
Montefiore Medical Center/Albert Einstein College of MedicineResidency, Pediatrics, 2011 - 2014
New York University School of MedicineClass of 2011
Certifications & Licensure
MI State Medical License 2022 - 2025
TX State Medical License 2017 - 2024
ND State Medical License 2014 - 2014
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- Pediatric relapsed/refractory ALK-positive anaplastic large cell lymphoma treatment and outcomes in the targeted-drug era.Lianna J Marks, Victor Ritter, Jennifer E Agrusa, Kala Y Kamdar, Julie Rivers
Blood Advances. 2025-03-25 - 10 citationsAcute and Late Pulmonary Effects After Radiation Therapy in Childhood Cancer Survivors: A PENTEC Comprehensive Review.Tina Marie Briere, Jennifer E Agrusa, Mary K Martel, Andrew Jackson, Arthur J Olch
International Journal of Radiation Oncology, Biology, Physics. 2024-06-01 - 2 citationsClinical, radiological and molecular responses to combination chemotherapy with MAPK pathway inhibition in relapsed and refractory Langerhans cell histiocytosis.Vivekanudeep Karri, Howard Lin, Jessica Velazquez, Akanksha Batajoo, Deevyashali Parekh
British Journal of Haematology. 2024-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
